Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Neuroblastoma 8Prostatic Neoplasms 3Skin Neoplasms 2Sarcoma, Ewing 2Precancerous Conditions 2Osteosarcoma 2Neuroectodermal Tumors, Primitive 2Medulloblastoma 2Glioma 2Carcinoma, Basal Cell 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Typical Teratoid Rhabdoid Tumor 1Stomach Neoplasms 1Rhabdoid Tumor 1Osteosarcoma Recurrent 1Oligodendroglioma 1Non-melanoma Skin Cancer 1Lymphoma, Follicular 1Lung Neoplasms 1Keratosis, Actinic 1Glioblastoma 1Gastritis, Atrophic 1Esophageal Neoplasms 1Diffuse Intrinsic Pontine Glioma 1Carcinoma, Non-Small-Cell Lung 1Astrocytoma 1

Interventions

Diclofenac 2whole grape extract 1Vitamin E 1Tomography, Optical Coherence 1Selenium 1Negative-Pressure Wound Therapy 1Eflornithine 1Dermoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Non-melanoma Skin Cancer × Eflornithine × Clear all
NCT04091022 2025-12-17

Topical Diclofenac and Topical DFMO Chemoprevention Trial in Subjects With a History of Skin Cancer

University of Alabama at Birmingham

Phase 2 Completed
64 enrolled
Dermatologic

Non-melanoma Skin Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡